ComplianceQuest

ComplianceQuest is an AI-powered enterprise quality management system (EQMS) vendor, built entirely on the Salesforce platform. Founded in 2013 and headquartered in Tampa, Florida, it serves 300+ organisations across life sciences, manufacturing, aerospace, automotive and food & beverage.

The company employs 446 people globally, with offices in the United States, United Kingdom, India, Singapore and Australia. It raised $36M in Series A funding from Insight Partners in September 2019, designated for product development and global expansion. The flagship product integrates quality, environmental health & safety (EHS) and compliance processes on a single Salesforce-native platform. Recent additions include the CQ.AI artificial intelligence engine and LifeQuest 360, a Salesforce Life Sciences Cloud integration announced in February 2025.

ComplianceQuest serves the broader life sciences industry, including pharmaceuticals, biotechnology, medical devices and contract manufacturing organisations. It does not serve pharmaceutical customers exclusively; it also markets to aerospace, automotive and food & beverage. In February 2025 the company announced LifeQuest 360, a pharma-specific quality management product integrating with Salesforce Life Sciences Cloud to unify quality, commercial and medical affairs operations on a single platform.

Pharmaceutical-specific messaging addresses compliance with FDA 21 CFR Part 11, EU Annex 11, ISO 13485 and ICH Q10. Pharma-focused capabilities include document control, electronic batch records, supplier quality management, CAPA, deviation management, complaint handling and audit management.

Pharmaceutical customer names are undisclosed on the vendor website and in marketing materials. The company states it serves "300+ companies"; the figure is undated and may not reflect current active customers. No case study names a pharmaceutical customer.

ComplianceQuest raised $36M in Series A funding in September 2019, led by Insight Partners, a global software investor with over $90 billion in assets under management whose portfolio includes Shopify, Twitter and DocuSign. The funding was designated for product development, expansion of the CQ.AI platform and global market expansion.

Revenue, profitability and revenue growth are undisclosed. No funding rounds beyond the 2019 Series A have been announced. No mergers, acquisitions or pending sale transactions have been announced. No IPO plans have been disclosed.

ComplianceQuest's EQMS platform is built entirely on the Salesforce force.com infrastructure. The flagship product includes 18+ integrated modules: document management, design controls, CAPA, change control, audit management, training, supplier management, customer complaints, nonconformance, risk management, equipment management and calibration.

All quality processes are integrated within the Salesforce ecosystem on a single platform. CQ.AI, an artificial intelligence engine added to the product, provides automated trend recognition, predictive quality insights, intelligent risk scoring and compliance intelligence across quality events. In February 2025 the company announced LifeQuest 360, a pharma-specific edition integrating quality management with Salesforce Life Sciences Cloud for unified commercial, medical and quality operations.

The platform architecture uses Salesforce's cloud infrastructure for security (SOC 2, ISO 27001) and mobile access via Salesforce Mobile, and integrates with Salesforce CRM, Sales Cloud and Service Cloud. Low-code/no-code configuration inherited from the Salesforce platform lets customers customise workflows, forms and dashboards without traditional software development.

ComplianceQuest's primary technology partnership is with Salesforce; the platform is built entirely on the Salesforce force.com infrastructure. The partnership lets customers use existing Salesforce licences, unify quality data with CRM and sales data, and integrate quality processes with Sales Cloud, Service Cloud and other Salesforce products. In February 2025 the company added Salesforce Life Sciences Cloud integration through the LifeQuest 360 product, extending the Salesforce partnership for pharmaceutical and life sciences customers.

The Salesforce architecture provides integration with the broader Salesforce ecosystem and AppExchange. No dedicated implementation partner network, consulting alliance or third-party systems-integration partnership is featured on public website materials. No industry affiliation with a pharmaceutical or quality-management association (ISPE, PQG, ASQ) is highlighted in marketing materials. Implementation is delivered through internal services and Salesforce's built-in integration framework.

Support is available through email, phone and web portal submission, backed by offices across US, UK, India, Singapore and Australia time zones. Support hours (24/7 versus business hours) and response-time SLAs are undisclosed.

Professional services include implementation and deployment, validation support for FDA-regulated industries, data migration from legacy QMS systems, integration services with Salesforce and third-party applications, training programmes for administrators and end users, and ongoing customer success management. Implementation timelines and methodologies are undisclosed. A resource centre offers whitepapers, datasheets and recorded webinars. No customer community programme, user conference or administrator certification programme is publicised.

Third-party review ratings: 4.7/5 on GetApp (100 reviews), 4.6/5 on G2 (89 reviews) and 4.7/5 on Capterra (106 reviews), an aggregate of 4.67/5 across the three platforms. The platform holds FrontRunner recognition in the Quality Management category from Gartner's Software Advice.

Leadership includes CEO Karthik Subramanian and CTO Arvind Radhakrishnan; detailed executive backgrounds are undisclosed on the company website. Company-level ISO certifications (ISO 9001, ISO 27001, SOC 2) are not displayed on public website materials. The platform inherits Salesforce's security certifications for the underlying infrastructure, including SOC 2 Type II and ISO 27001.

The company publishes thought-leadership content through a blog, a resource centre of whitepapers, and webinars on quality management, regulatory compliance and industry trends. Case studies are available; pharmaceutical-sector customer names are undisclosed.

The company maintains an actively updated website with a resource centre of blog articles, whitepapers, datasheets, recorded webinars and product videos. Recent press releases include the LifeQuest 360 announcement (February 2025) and various product-enhancement announcements. It maintains a LinkedIn presence with regular posts on product updates, industry trends and company news.

The website offers product demos and consultation requests through standard contact forms, and a free trial is offered on the pricing page. ComplianceQuest is featured in QMS software comparison guides, review platforms (GetApp, G2, Capterra, Software Advice) and B2B software directories.

The company participates in industry events and webinars in the quality management and life sciences markets.